生物标志物 生物标志物
Nicolás Lamanna-Rama1,2, Marta Casquero-Veiga2,3, Carlos Ceron2
1Consejo Superior de Investigaciones Científicas - Centro Internacional de Neurociencia Cajal (CSIC - CINC), Alcalá de Henares, Madrid, Spain.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
概括
阿尔茨海默病 (AD) 涉及脑血管中的纤维素积累,导致神经退行. 在BioClotAD项目中,开发了纤维素结合探针,用于早期检测和潜在的抗凝剂治疗.
科学领域:
- 神经科学是一个神经科学.
- 生物标志物开发 生物标志物开发
- 医疗成像医学成像
背景情况:
- 阿尔茨海默病 (AD) 是最常见的痴呆症,其特征是复杂的神经病理学.
- 一个原血栓状况,导致脑血管中的纤维素积累,与AD病变发生有关.
- 纤维素沉积会加剧AD患者的一个子集的低流,神经退行和血脑屏障破坏.
研究的目的:
- 开发新的成像生物标志物,以非侵入性地检测AD中的前凝状态.
- 使用纤维素结合探针 (FBPs) 识别大脑纤维素积累.
- 建立早期检测方法,以识别可能受益于抗凝药疗法的AD患者.
主要方法:
- 在BioClotAD项目中,在多个欧洲地点采用了体外,体外和体内测试.
- 纤维素结合探针 (FBPs) 在体内通过核成像检测大脑遮时进行测试.
- 与转移素受体抗体 (FBP-TfR) 结合的FBP被开发用于增强光学和核成像的血脑屏障透,在人类AD脑样本中进行验证.
主要成果:
- 开发了可行的神经成像策略,以检测和定位AD模型中的体内纤维素积累.
- 该研究确定了脑纤维素沉积的特定区域分布.
- 这些发现为未来的临床试验奠定了基础,研究AD中纤维素的神经成像.
结论:
- 开发的神经成像生物标志物使得在AD中早期检测出血栓前期状态.
- 这种早期检测为个性化抗凝药疗法提供了机会,有可能延迟疾病的进展.
- 生物ClotAD项目为推进阿尔茨海默病的诊断和治疗方法铺平了道路.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
746
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
746
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
511
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
511